Atrial Fibrillation Patient Preference Study

NCT02611635 · clinicaltrials.gov ↗

COMPLETED

Status

382

Enrollment

INDUSTRY

Sponsor class

Conditions

Atrial Fibrillation

Interventions

DRUG: VKA: Warfarin (Waran)
DRUG: NOAC: Rivaroxaban (Xarelto, BAY59-7939)
DRUG: NOAC: Dabigatran etexilate
DRUG: NOAC: Apixaban
DRUG: NOAC: Edoxaban
DRUG: NOAC: Lixiana

Sponsor

Bayer